阿斯達克財經網 大智慧阿思達克通訊社12月1日訊,國家食藥監總局(CFDA)網站信息顯示,華海藥業(600521.SH)3.1類新藥左乙拉西坦緩釋片臨床申報獲受理。值得一提的是,左乙拉西坦普通片劑在國內已有三家企業生產,緩釋制劑尚無企業獲批。 公開資料顯示,左乙拉西坦主要用於治療 ... and more »
Medical News Today Candesartan has a significantly lower risk of death at one to five years than losartan when given to patients with heart failure, Swedish researcher...
Dove Medical Press Patients and methods: In this prospective, open-label, single-group study, 106 previously untreated patients with a baseline systolic blood pressure (SBP) of 150–200 mmHg, and a diastolic blood pressure (DBP) of 110 to 120 mmHg, started with ...
Science World Report In a collaborative effort, researchers from St. Olavs Hospital in Trondheim, Norway and the Norwegian University of Science and Technology (NTNU) ha...
Drug Discovery & Development Takeda Pharmaceutical Co. Ltd. received notice of sanctions imposed by the Japan Pharmaceutical Manufacturers Association (JPMA) for promotional activities regarding Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J). The sanctions ...
Medscape BOSTON — The angiotensin receptor blocker candesartan (Atacand, AstraZeneca Pharmaceuticals LP) is safe and as effective as the beta blocker propranolol in preventing migraine headaches, according to a new study. The results of the randomized, ...
iStockAnalyst (press release) For instance, Candesartan , the product we launched last November, is sold at a price that supports our gross margin. Our selling expenses for the three months ended September 30, 2014 were $0.7 million, compared to $0.9 million in the same period last ... and more »
Business Wire (press release) Global Market Report of Candesartan cilexetil (CAS 145040-37-5) aims at providing comprehensive data on Candesartan cilexetil globally and regionally (Europe, Asia, North America, Latin America etc.). It captures Candesartan cilexetil market trends ... and more »
FiercePharma Manufacturing According to four notices in the most recent FDA Enforcement Report, Apotex is recalling 65,442 bottles of candesartan cilexetil made at the company's plant in Bangalore after testing found they contained excessive levels of impurities. The FDA banned ...
